ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,877Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 80

$1.01M Total Retail Price of All Prescriptions

Rank: 18 out of 80

386 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Pennsylvania
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 43%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $343 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 482 432 88 1 4
SIMVASTATIN 355 320 60 2 11
FUROSEMIDE 262 231 51 3 23
HYDROCODONE-ACETAMINOPHEN 244 117 44 S3 4 17
AMLODIPINE BESYLATE 240 215 39 5 7
METFORMIN HCL 230 225* 37 6 15
METOPROLOL TARTRATE 224 206 31 7 21
LORAZEPAM 218 180 38 B 8 51
PANTOPRAZOLE SODIUM 210 205* 42 9 31
LEVOTHYROXINE SODIUM 209 204* 31 10 22
CLOPIDOGREL 170 165* 27 11 28
SERTRALINE HCL 166 142 26 12 30
OMEPRAZOLE 166 133 27 12 8
DIOVAN 164 151 24 14 73
POTASSIUM CHLORIDE 153 148* 29 15 37
ATENOLOL 138 133* 23 16 26
METOPROLOL SUCCINATE 130 125* 23 17 29
WARFARIN SODIUM 128 110 17 18 49
GABAPENTIN 128 109 31 18 16
ALLOPURINOL 127 90 20 20 66
ZOLPIDEM TARTRATE 122 71 18 21 35
ALPRAZOLAM 115 90 18 B 22 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 106* 17 23 44
OXYCODONE HCL 110 <11 <11 S2 24 40
HYDROCHLOROTHIAZIDE 106 101* 23 25 13
DIGOX 101 89 12 26 95
VALSARTAN-HYDROCHLOROTHIAZIDE 98 77 14 27 96
DONEPEZIL HCL 97 84 15 28 65
AZITHROMYCIN 91 76 60 29 97
NEXIUM 82 63 17 30 100
FENTANYL 80 <11 <11 S2 31 68
OXYCODONE-ACETAMINOPHEN 74 37 13 S2 32 42
TRAMADOL HCL 73 55 21 33 27
PRAVASTATIN SODIUM 72 67* 16 34 14
LOSARTAN POTASSIUM 68 63* 12 35 32
KLOR-CON M20 66 66 13 36 88
CEPHALEXIN 65 60* 19 37 34
CELEBREX 64 59* 14 38 112
ATORVASTATIN CALCIUM 64 59* 12 38 10
TRUVADA 63 <11 <11 40 2
ALENDRONATE SODIUM 63 63 11 40 58
TRAZODONE HCL 62 <11 <11 42 43
SYNTHROID 61 47 12 43 118
AMITRIPTYLINE HCL 58 <11 <11 R 44 62
NAMENDA 57 <11 <11 45 88
AMOXICILLIN 56 51* 41 46 124
FENOFIBRATE* 56 <11 <11 46 76
ZETIA 55 <11 <11 48 91
NOVOLOG FLEXPEN 55 37 13 48 125
CARVEDILOL 54 <11 <11 50 39
TEMAZEPAM 54 <11 <11 B 50 126
NIFEDIPINE ER 54 <11 <11 50 60
LANSOPRAZOLE 53 <11 <11 53 127
CRESTOR 53 <11 <11 53 45
CEFUROXIME 52 47* 35 55 128
PROMETHAZINE HCL 52 47* 35 R 55 128
OXYCONTIN 52 <11 <11 S2 55 128
DETROL LA 51 <11 <11 58 134
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 46* 18 58 20
DIAZEPAM 50 <11 <11 B 60 136
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.